The global sleep apnea devices market is broadly segmented into two categories, namely, Diagnostic Devices and Therapeutic Devices. The industry is technology driven and technological advancements in both diagnostic and therapeutic devices such as PSG devices, screening devices, actigraphy systems, Positive Airway Pressure (PAP) devices, humidifiers, adaptive servo-ventilation systems, oxygen devices, oral appliances, and accessories have enhanced patient compliance levels in recent years.
(Rocky) Jaipur Call Girl - 9521753030 Escorts Service 50% Off with Cash ON De...
Sleep apnea diagnostic & therapeutic devices market end user analysis, competitive landscape & forecast to 2017
1. Sleep Apnea Diagnostic & Therapeutic Devices Market : End-user Analysis,
Competitive Landscape & Forecast to 2017
Sleep problems are touted as a ‘global epidemic’ and sleep apnea is a crucial contributor to this
disorder. Obstructive Sleep Apnea (OSA) is the most common type of sleep apnea; around 84% of
people with sleep apnea are diagnosed with the disease. Studies suggest that about 100 million
people worldwide are suspected to have obstructive sleep apnea, of which more than 80% remain
undiagnosed.
Buy Your Copy of Report: http://www.reportsnreports.com/reports/181606-sleep-apnea-diagnostic-
therapeutic-devices-market-end-user-analysis-competitive-landscape-forecast-to-2017.html
Report Details:
Published: July 2012
Price Single User License: US $ 4650 Price Corporate User License: US $ 7150
The global sleep apnea devices market is broadly segmented into two categories, namely,
Diagnostic Devices and Therapeutic Devices. The industry is technology driven and technological
advancements in both diagnostic and therapeutic devices such as PSG devices, screening devices,
actigraphy systems, Positive Airway Pressure (PAP) devices, humidifiers, adaptive servo-
ventilation systems, oxygen devices, oral appliances, and accessories have enhanced patient
compliance levels in recent years.
Incessantly rising obesity and incidence of sleep apnea, increasing awareness regarding
hypertension, stroke, Type II diabetes/adult onset diabetes and cardiovascular diseases and its
association with sleep apnea, increased adoption and acceptance of home sleep testing devices,
growing preference for oral appliances, technological advancement in diagnostic/therapeutic
devices, and upcoming novel therapies are the major drivers that are slated to propel this market,
while limited reimbursement, coupled with lack of patient compliance is a pivotal factor restraining
the growth of this market. The market is dominated by global players like Philips Respironics,
ResMed, Inc., Natus Medical Incorporated, Fisher and Paykel Healthcare, Compumedics Limited,
and CareFusion Corporation, among others.
The diagnostic devices and therapeutic devices segments will grow at a CAGR of 15% and 17%,
respectively, by 2017. The diagnostic devices market is propelled by PSG devices, particularly
clinical PSG devices. The usage of Ambulatory PSG devices is slated to increase in the next few years
2. due to observed patient preference to be tested at home for convenience reasons, patient’s
inclination to skip the unfamiliar environment of sleep labs, and cost–effectiveness of these devices.
The global demand for other diagnostic devices such as respiratory polygraphs, two channel
screening devices, single channel screening devices, and actigraphy systems is also on the rise due
to their low costs. These devices serve as cost-effective and convenient options, as compared to PSG
devices, especially for the low-economic class patient pool.
The therapeutic devices market is predominantly driven by PAP devices, as these are considered to
be the first line treatment for sleep apnea and hence are most prescribed by sleep specialists.
Insurance cover for PAP devices and other supplies in developed geographies like the U.S. and
select countries in Europe is expected to boost its demand. However, non- compliance issue with
PAP devices is expected to boost the growth of the oral appliances market. The accessories market
was the largest in 2011, in terms of volume, as they are an integral component of sleep apnea
diagnostic and therapeutic devices. With a growing sleep apnea patient pool, the demand for sleep
apnea diagnostic/therapeutic devices and accessories is bound to grow.
The global sleep apnea devices market is dominated by North America, followed by Europe, Asia,
and Rest of the World (RoW). North America will continue to lead the sleep apnea device market in
the years to come, followed by Europe. As reimbursement policies become more consistent across
European countries, sustained steady growth is expected from the region in the coming years. The
Asian region’s contribution to the global sleep apnea device market is expected to pick up in the
coming years as the medical condition gets more recognition from both patients and the medical
fraternity alike.
Scope of the Report
The sleep apnea devices market research report categorizes the global market into Diagnostic
Devices and Therapeutic Devices. Both of these markets are broken down into segments and sub-
segments, providing exhaustive value-volume analysis for 2009, 2010 and 2011, as well as forecast
up to 2017. Each market is comprehensively analyzed at a granular level by geography (North
America, Europe, Asia, and Rest of the World) to provide in-depth information on the global
scenario. A separate segment of end-user analysis is also incorporated in the report to provide
information on devices that are used exclusively at hospital or at home and devices that are used at
both places.
3. Global sleep apnea market, by segments
Diagnostic Devices
Therapeutic Devices
Global sleep apnea diagnostic devices market, by products
Polysomnography (PSG) Devices
Clinical PSG Devices
Ambulatory PSG Devices
Respiratory polygraphs
Two Channel Screening Devices (Nasal Flow Sensors, SPO2)
Single Channel Screening Devices (Pulse Oximeters)
Actigraphy Systems
Global sleep apnea therapeutic devices market, by products
Positive Airway Pressure (PAP) Devices
CPAP Devices
APAP Devices
Bi-level Devices
Facial Interfaces
Masks
Full Face Masks
Nasal Masks
Nasal Pillow Masks
Oral Masks
Adaptive Servo-Ventilation
Airway Clearance Systems
Oxygen Devices
4. Concentrators
Home Oxygen Filling Systems
Liquid Portable Oxygen
Accessories
Pillows
Masks Cleaning Wipes
Chin Restraints
Tube Covers
Filters
DC Convertors
Power & Batteries
Headgears
Nebulizers
Tubings
Humidifiers
Others
Oral Appliances
Mandibular Advancement Device (MAD)
Tongue Retaining Device (TRD)
Others
Novel therapies
Global sleep apnea market, by end-users
Home Devices
Hospital Devices
Both (Home and Hospital) Devices
5. Sleep apnea market, by geography
North America
Europe
Asia
Rest of the World (RoW)
Table Of Contents
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 STAGES OF SLEEP
3.1.1.1 Sleep Cycle
3.1.2 SLEEP DISORDERS
6. 3.1.3 SLEEP APNEA
3.1.4 ANATOMY OF SLEEP APNEA EPISODE
3.1.5 CLASSIFICATION OF SLEEP APNEA
3.1.6 CAUSES
3.1.6.1 Central sleep apnea (CSA)
3.1.6.2 Obstructive sleep apnea (OSA)
3.1.7 SIGNS & SYMPTOMS
3.1.7.1 Central sleep apnea
3.1.7.2 Obstructive sleep apnea
3.1.7.3 Signs and symptoms in children
3.1.8 RISK FACTORS
3.1.8.1 Central sleep apnea
3.1.8.2 Obstructive Sleep Apnea
3.1.9 DIAGNOSIS
3.1.9.1 Sleep apnea diagnosis & sleep recording test
3.1.10 TREATMENT OPTIONS
3.1.11 CO-MORBID CONDITIONS
3.2 MARKET DYNAMICS
3.2.1 PORTER'S FIVE FORCES ANALYSIS
3.2.1.1 Threat of new entrants
3.2.1.2 Supplier's bargaining power
3.2.1.3 Buyer's bargaining power
3.2.1.4 Segment rivalry
3.2.1.5 Threat of substitutes
3.2.2 DRIVERS
7. 3.2.2.1 Colossal pool of sleep apnea patients
3.2.2.2 Increasing awareness
3.2.2.3 Growing usage of oral appliances
3.2.2.4 Technological advancements
3.2.3 RESTRAINTS
3.2.3.1 Reimbursement concerns
3.2.3.2 Lack of patient compliance
3.2.4 MARKET SHARE, BY KEY PLAYERS
4 GLOBAL SLEEP APNEA DEVICES MARKET, BY SEGMENTS
4.1 INTRODUCTION
5 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCTS
5.1 INTRODUCTION
5.2 POLYSOMNOGRAPHY (PSG) DEVICE
5.2.1 CLINICAL PSG DEVICE
5.2.2 AMBULATORY PSG DEVICE
5.3 RESPIRATORY POLYGRAPH
5.4 TWO CHANNEL SCREENING DEVICES (NASAL FLOW SENSORS, SPO2)
5.5 SINGLE CHANNEL SCREENING DEVICES (PULSE OXIMETERS)
5.5.1 HAND-HELD PULSE OXIMETERS
5.5.2 FINGERTIP PULSE OXIMETERS
5.5.3 TABLE-TOP PULSE OXIMETERS
5.5.4 WRIST-WORN PULSE OXIMETERS
5.6 ACTIGRAPHY SYSTEMS